Documentos relacionados

1. Primary antiphospholipid syndrome associated with anti-phospholipase A2 receptor antibody-positive membranous nephropathy.
2. The Prevalence, Characteristics, and Putative Mechanisms of Dual Antigen-Positive Membranous Nephropathy: The Underestimated Condition.
3. Preference for anti-phospholipase A2 receptor antibody assay in patients with suspected membranous nephropathy: a survey study on medical practice after publication of Japanese Guidelines for Nephrotic Syndrome 2020.
4. Clinical implications of serum anti-PLA2R levels and glomerular PLA2R deposits in primary membranous nephropathy.
5. Combined Assessment of Phospholipase A2 Receptor Autoantibodies and Glomerular Deposits in Membranous Nephropathy.
6. Clinical Relevance of Domain-Specific Phospholipase A₂ Receptor 1 Antibody Levels in Patients with Membranous Nephropathy.
7. Negative anti-phospholipase A2 receptor antibody status at three months predicts remission in primary membranous nephropathy.
8. Diagnosis of membranous nephropathy with Anti-GBM glomerulonephritis: a case series report.
9. [Membranous glomerulonephritis : An example of individualized medicine in nephrology].
10. Noninvasive diagnosis of primary membranous nephropathy using phospholipase A2 receptor antibodies.